Germany · Delayed Price · Currency is EUR BioGaia AB Company Description
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula.
The Adult Health segment provides gut health tablets, bone health tablets and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee’s dairy product.
The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels.
BioGaia AB (publ) was incorporated in 1990 and is based in Stockholm, Sweden.
| Country | Sweden |
| Founded | 1990 |
| Industry | Pharmaceutical Preparations |
| Employees | 225 |
| CEO | Theresa Agnew |
Contact Details
Address: Kungsbroplan 3 Stockholm, 112 27 Sweden | |
| Phone | 46 8 55 52 93 00 |
| Website | biogaiagroup.com |
Stock Details
| Ticker Symbol | BGLA |
| Exchange | Frankfurt Stock Exchange |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Theresa Agnew | Chief Executive Officer |
| Alexander Kotsinas | Chief Financial Officer |
| Ludvig Milesson | Chief Operating Officer |